» Articles » PMID: 16190798

Treatment Incidence and Patterns in Children and Adolescents with Autism Spectrum Disorders

Overview
Publisher Mary Ann Liebert
Date 2005 Sep 30
PMID 16190798
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

This study examined the treatment rates and patterns in children and adolescents with autism spectrum disorders (ASDs). Data were collected on 353 nonreferred children and adolescents (mean age 9.5 +/- 3.9 years; range 3-21 years) with ASDs from public schools across Ohio. Parents provided information on the use of psychotropic medicines, vitamins, supplements, and modified diets. They also completed measures of social competence, problem behavior, and adaptive behavior. Results indicated that 46.7% of subjects had taken at least one psychotropic medication in the past year. In addition, 17.3% of subjects had taken some type of specially formulated vitamin or supplement, 15.5% were on a modified diet, 11.9% had some combination of psychotropic medication and an alternative treatment, and 4.8% had taken an anticonvulsant. Logistic regressions indicated that greater age, lower adaptive skills and social competence, and higher levels of problem behavior were associated with greater medication use. This was the first study to focus exclusively on a younger population, to survey patterns of modified diets, and to obtain standardized ratings of social competence, problem behaviors, and adaptive behavior in relation to medication use. The results of this study highlight the need for more research on psychotropic medication in children and adolescents with ASDs.

Citing Articles

The use of psychotropic medications in autistic individuals (21 years and younger) in Western Australia: A preliminary investigation.

Bulonza R, Watkins K, Parsons R, Sunderland B, Whitehouse A, Caccetta R Autism. 2024; 28(8):2002-2013.

PMID: 38385262 PMC: 11301957. DOI: 10.1177/13623613231226099.


Pharmacological intervention for irritability, aggression, and self-injury in autism spectrum disorder (ASD).

Iffland M, Livingstone N, Jorgensen M, Hazell P, Gillies D Cochrane Database Syst Rev. 2023; 10:CD011769.

PMID: 37811711 PMC: 10561353. DOI: 10.1002/14651858.CD011769.pub2.


Report of the ABAI Task Force on Contingent Electric Skin Shock.

Perone M, Lerman D, Peterson S, Williams D Perspect Behav Sci. 2023; 46(2):261-304.

PMID: 37425985 PMC: 10323060. DOI: 10.1007/s40614-023-00379-w.


Concomitant medication use in children with autism spectrum disorder: Data from the Autism Biomarkers Consortium for Clinical Trials.

Shurtz L, Schwartz C, DiStefano C, McPartland J, Levin A, Dawson G Autism. 2022; 27(4):952-966.

PMID: 36086805 PMC: 9995606. DOI: 10.1177/13623613221121425.


Many Young Children with Autism Who Use Psychotropic Medication Do Not Receive Behavior Therapy: A Multisite Case-Control Study.

Wiggins L, Nadler C, Rosenberg S, Moody E, Reyes N, Reynolds A J Pediatr. 2021; 232:264-271.

PMID: 33493493 PMC: 8174527. DOI: 10.1016/j.jpeds.2021.01.043.